text_1: Combination nicotine replacement therapies with varenicline or bupropion lead to significantly higher long-term abstinence rates at 52 weeks than varenicline monotherapy.
text_2: Five hundred six adult (≥18 years) cigarette smokers were randomly assigned and 315 (62%) completed the study.